Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
Muhammad Shahzeb Khan, Matthew W. Segar, Muhammad Usman, Kershaw V. Patel, Harriette G.C. Van Spall, Adam D. DeVore, Muthiah Vaduganathan, Carolyn S.P. Lam, Faı̈ez Zannad, Subodh Verma, Javed Butler, W.H. Wilson Tang, Ambarish Pandey
Topics & Concepts
CanagliflozinMedicineInternal medicineDiabetes mellitusHeart failurePlaceboBody mass indexFramingham Risk ScoreRelative riskCumulative incidenceIncidence (geometry)Absolute risk reductionCardiologyType 2 diabetesConfidence intervalEndocrinologyDiseaseCohortPhysicsPathologyAlternative medicineOpticsDiabetes Treatment and ManagementHeart Failure Treatment and ManagementDiabetes Management and Research